Latest lung cancer Stories

CALGARY, March 5, 2013 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that it has completed patient enrollment in a Phase 2 clinical trial evaluating intravenous administration of REOLYSIN(®) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with Kras or EGFR-activated tumours (REO 016). This trial is a single arm, single-stage, open-label, Phase 2 study of REOLYSIN given...

Mesothelioma Law Firm Baron and Budd Repeats Platinum Sponsorship to ADAO International Conference Focused on New Trends for Treatment. Dallas, TX (PRWEB) March 04, 2013 According to the American Lung Association, lung cancer was the leading cause of cancer deaths among women in 2012. At a massive toll of 72,590 female lives, the number is nearly twice that attributed to breast cancer. Over the last 33 years, the rate of new lung cancer cases has surged 106 percent for women, compared to...

Hagel passed pivotal lung cancer legislation and has been personally impacted by the disease SAN FRANCISCO, Feb. 26, 2013 /PRNewswire-USNewswire/ -- Bonnie J. Addario and the Bonnie J. Addario Lung Cancer Foundation salute and applaud Chuck Hagel's nomination and Senate confirmation as the 24(th) United States Secretary of Defense. Hagel has been directly affected by lung cancer - his mother died from the disease. (Photo: http://photos.prnewswire.com/prnh/20130226/DC67173)...

A protein involved in the internal cell scaffold is associated with increased risk of metastasis and mortality in a range of common cancers finds a meta-analysis published in Biomed Central's open access journal BMC Medicine. The protein, fascin-1, is involved in bundling together the actin filaments which form the internal scaffolding of a cell and are involved in cell movement. Though it is absent, or only present at a low level in normal epithelial cells, several small studies have...

Betsy Thurston joins LUNGevity as Vice President of Development WASHINGTON, Feb. 22, 2013 /PRNewswire-USNewswire/ -- LUNGevity Foundation is pleased to announce that Betsy Thurston has joined the senior management team as Vice President of Development. In her role, Ms. Thurston will have overall responsibility for all fundraising and development activities including the development of key external alliances. Ms. Thurston will be a part of LUNGevity's senior management team that...

Same Stigmatization Blocks Access to Low Dose CT Screening for Lung Cancer WASHINGTON, Feb. 21, 2013 /PRNewswire-USNewswire/ -- Lung Cancer Alliance and Legacy join other public health advocates in opposing a provision in the Affordable Care Act that permits health insurance companies to charge premiums to smokers that are 50% higher than non-smokers. "What is most upsetting about the increased premiums from a public health perspective is that we know that most smokers today want...

LOS ANGELES, Feb. 20, 2013 /PRNewswire/ -- Launching today, Lung Cancer Foundation of America's new website - http://www.lcfamerica.org/ - is a formidable novel tool for anyone facing lung cancer or seeking information about this disease, including patients, families, the medical community, the public at-large and the media. The centerpiece of the new website is a unique video guidebook for those diagnosed with lung cancer with segments led by the superstars of lung cancer research...

Lung cancer is likely to overtake breast cancer as the main cause of cancer death among European women by the middle of this decade, according to new research published in the cancer journal Annals of Oncology today (Wednesday). In the UK and Poland it has already overtaken breast cancer as the main cause of cancer deaths in women. The study by researchers in Italy and Switzerland predicts that just over 1.3 million people will die from cancer (737,747 men and 576,489 women) in the 27...

Full Service National Reference Laboratory, PAML, leader in its field, introduces blood test to aid in the early detection of lung cancer. (PRWEB) February 12, 2013 PAML (Pathology Associates Medical Laboratories, LLC) announced today that it has entered into an agreement with Oncimmune® USA LLC to offer the EarlyCDT®-Lung test. EarlyCDT-Lung is an innovative blood test that aids in the risk assessment and the early detection of lung cancer. Lung cancer is the leading cause of...

Differences in treatment likely to have key role too Stage at diagnosis only partly explains the wide variation in lung cancer survival rates among different developed countries, indicates a large study of nearly 60,000 patients, published online in Thorax. Other factors, such as treatment, are also likely to have a key role, say the authors. Stage at diagnosis has often been suggested as one of the primary reasons why lung cancer survival is low in certain countries, such the UK, on...